CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies Effects of Vildagliptin on Ventricular Function in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Randomized Placebo-Controlled Trial Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis

Expert Opinion03 January 2021

JOURNAL:Eur Heart J. Article Link

The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

H Bueno, B Moura, P Lancellotti et al. Keywords: heart failure; cardiomyopathies

Full Text PDF